'Long pending orders executed': Bharat Biotech resumes exports of Covaxin

India restarted on Friday exports of Covid-19 shots to COVAX for the first time since April

Indian vaccine maker Bharat Biotech said on Monday it has resumed export of its COVID-19 shot, Covaxin, and has executed long-pending orders in November.
 

The company also said exports to additional countries will commence from December, according to a statement it shared on Twitter.
 

It was not immediately clear whether or not these exports were made under the global vaccine-sharing facility COVAX.

Covaxin, which is 78% effective against severe cases of COVID-19, was approved for emergency use listing by the World Health Organization earlier this month.
 

It is the only homegrown vaccine being used in India's vaccination programme, although it accounts